Neurological symptoms in a patient on anti-TNF therapy, methotrexate and prednisolone for rheumatoid arthritis

被引:2
|
作者
Bach, M. [1 ]
Schob, S. [2 ]
Baerwald, C. [1 ]
机构
[1] Univ Klinikum Leipzig, Bereich Rheumatol, Med Klin & Pol 3, Liebigstr 20,Haus 4, D-04103 Leipzig, Germany
[2] Univ Klinikum Leipzig, Abt Neuroradiol, Liebigstr 20, Leipzig, Germany
来源
INTERNIST | 2020年 / 61卷 / 03期
关键词
Toxoplasmosis; cerebral; Tumor necrosis factor alpha inhibitors; Opportunistic infections; Immunosuppression; Antirheumatic agents;
D O I
10.1007/s00108-019-00727-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 78-year-old woman with rheumatoid arthritis on TNF-alpha inhibitor, methotrexate and prednisolone presented with severe but unspecific symptoms such as leg weakness, shivering, bifrontal headache, nausea and staggering. The broad range of differential diagnoses lead to intricate and time-consuming diagnostic procedures. Serology, magnetic resonance imaging and microbiological investigations represent important steps to make the final diagnosis of cerebral toxoplasmosis. Both diagnostic approach and therapy require close cooperation of different disciplines. Therapies of rheumatoid arthritis as well as of toxoplasmosis are based on a long-term treatment and could be associated with numerous harmful side effects. Continuous monitoring and permanent adjustment of therapy regimes are therefore mandatory.
引用
收藏
页码:313 / 320
页数:8
相关论文
共 50 条
  • [21] BONE LOSS IN PATIENTS WITH RHEUMATOID ARTHRITIS: ANTI-TNF AND METHOTREXATE COMPARED WITH METHOTREXATE TREATMENT ALONE
    Vreju, F.
    Ciurea, P.
    Rosu, A.
    Florea, M.
    Musetescu, A.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 322 - 322
  • [22] RHEUMATOID ARTHRITIS International disparities in access to anti-TNF therapy
    Emery, Paul
    NATURE REVIEWS RHEUMATOLOGY, 2011, 7 (04) : 197 - 198
  • [23] Cutaneous manifestations during anti-TNF therapy in rheumatoid arthritis
    Solau-Gervais, E
    Lebas, D
    Duquesnoy, B
    Delaporte, E
    Flipo, R
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 458 - 458
  • [24] Biomarkers for prognosis of response to anti-TNF therapy of rheumatoid arthritis
    Stuhlmueller, B.
    Skriner, K.
    Haeupl, T.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2015, 74 (09): : 812 - +
  • [25] Anti-TNF Treatment in Rheumatoid Arthritis
    Geiler, Janina
    Buch, Maya
    McDermott, Michael F.
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (29) : 3141 - 3154
  • [26] Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases
    Peter C. Taylor
    Molecular Biotechnology, 2001, 19 : 153 - 168
  • [27] Polyneuropathy associated with anti-TNF therapy in patients with rheumatoid arthritis
    Jurand, J
    Zochodne, D
    Barr, S
    Voll, C
    Martin, L
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (07) : 1405 - 1405
  • [28] Rheumatoid arthritis: Biological therapy other than anti-TNF
    Rossi, Daniela
    Modena, Vittorio
    Sciascia, Savino
    Roccatello, Dario
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 27 (02) : 185 - 188
  • [29] The emerging role of anti-TNF therapy in the treatment of rheumatoid arthritis
    Lipsky, PE
    AMERICAN JOURNAL OF MANAGED CARE, 1999, 5 (08): : S506 - S509
  • [30] Influence of age on the outcome of anti-TNFα therapy in rheumatoid arthritis
    Radovits, Beata J.
    Kievit, Wietske
    Fransen, Jaap
    van de Laar, Mart A. F. J.
    Jansen, Tim L.
    van Riel, Piet L. C. M.
    Laan, Roland F. J. M.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S765 - S765